Home / Article
Explore how a needs-driven approach to electronic laboratory notebook selection can improve data integrity, reproducibility, and scientific continuity.
| 3 min read
The Atlas will enable the validation of genetic targets and training of AI models at unprecedented scale
| 1 min read
A new pilot under BioMed X’s XBridge framework aims to connect Harvard investigators with pharmaceutical researchers through structured matchmaking and sponsored research agreements.Article
Learn why data quality, governance, and collaboration are critical to realizing AI’s potential across the drug discovery pipeline.
| 2 min read
New grant boosts global access to biotherapeutics, leveraging advanced molecular design and reducing monoclonal antibody costs.
| 2 min read
New GlycoLiner kits enable rapid, covalent labeling of live-cell surface glycoproteins using gentle, self-catalyzing chemistry at neutral pH.
Discover how digital analytics tools empower researchers to streamline bioanalytical workflows, automate data management, and maintain biotherapeutic product quality.
| 2 min read
ProBioGen will apply its CHO.RiGHT platform and GlymaxX technology to support Spica’s first clinical candidate, the anti-CD163 antibody ST101.
| 2 min read
The milestone marks meaningful progress toward developing new therapeutic options for Alport syndrome, with first-patient dosing expected in early 2026.
| 3 min read
From vein-to-vein tracking to the plasmid bottleneck, logistics are the new efficacy endpoint
| 4 min read
Why the "make or buy" decision is no longer just about cost, but about the survival of the therapy itself
| 4 min read
How simulating the future is helping the industry abandon the "black box" of bioreactor biology
